Scroll Back to Top

 

Join us at AMP 2022 Annual Meeting & Expo 

 

November 1-5 | Phoenix, AZ | Booth #1102

 

Discover how we can provide you with the tools you need to deliver the promise of precision medicine to all patients

 

  • JOIN OUR WORKSHOPS 

    Please join our free workshops to learn how we are helping to democratize access to precision oncology for patients with cancer. Register here to save your seat and a chance to win a door prize.

    Wednesday, November 2, 2022

    8:00 AM to 8:50 AM - Workshop 1
    Implementing an FDA Cleared Comprehensive Genomic Profiling (CGP) Solution with a Path to Reimbursement

    9:00 AM to 9:50 AM - Workshop 2
    Liquid Biopsy - Improving Patient Access to Precision Oncology Through Centralized Services and Decentralized Kitted Solutions

     

  • VIEW OUR POSTERS
     

    #H010       KIT (D816V) Digital PCR Testing
    Authors:  Li Cai, Danny Overman, Scott Hood, Eddie Kallam, Taylor Jensen, Dan Wang, Lauren Kam Morgan, Anjen Chenn

     

    #ST028     Validation of genomic profiling by PGDX plasma focus to facilitate precision oncology through cell-free DNA testing of solid tumors.     
    Authors:  Ellen Verner, Stephanie Hastings, Eric Severson, Shakti Ramkassoon, Prasanth Reddy, Mary Nesline, Kenneth C. Valkenburg    


    #ST045     Pan Solid Tumor Identification of NTRK Fusions Utilizing RNA Sequencing Identifies Diverse Fusion Partners.     
    Authors:  Eric Severson, Mary Nesline, B.R Achyut, Sarabjot Pabla, Geoffrey Kannan, Anjen Chenn, Shengle Zhang, Roger Klein, Jeffrey Conroy, Mark Sausen, Pratheesh Sathyan, Kamal Saini, Taylor J. Jensen, Prasanth Reddy, Shakti Ramkissoon.     

    #ST046     Pan Solid Tumor Identification of NRG1 Fusions Utilizing RNA Sequencing Identifies Diverse Fusion Partners and Highlights a Lack of Co-occurring Oncogenic Driver Alterations.     
    Authors:  Eric Severson, Mary Nesline, B.R Achyut, Sarabjot Pabla, Geoffrey Kannan, Anjen Chenn, Shengle Zhang, Roger Klein, Jeffrey Conroy, Mark Sausen, Pratheesh Sathyan, Kamal S. Saini, Taylor J. Jensen, Prasanth Reddy, Shakti Ramkissoon.

    #ST060     Combined low-pass whole genome and targeted sequencing identifies causative mutations and associated genomic scarring indicative of homologous recombination deficiency.     
    Authors:  Jie An, Gillian Belbin, Chase Mazur, Jeremy Li, Joseph Pickrell, Dan Metzger, Shuang Gao, Erik Van Roey, R.J. Seager, Sarabjot Pabla, Durga Prasad Dash, Jeffrey Conroy.    

    #ST077     Assessing Variability Across HRD Assays: Findings from the Friends’ HRD Harmonization Project.     
    Authors:  Hillary Stires, Zhiwei Zhang, Lisa McShane, Jonathan Bieler, Li Chen, Vincent Funari, Mohit Gupta, Alexander J. Lazar, Brittany McKelvey, Sarabjot Pabla, Jerod Parsons, Daniel Saul, Omar Serang, Ethan Sokol, Elizabeth Starks, Shuang Yang, Jennifer Yen, Mark Stewart, Jeff Allen.

    #TT033     Validation of a 33-gene pan-cancer circulating tumor DNA-based next-generation sequencing assay.
    Authors:  Amber R. Schneider, Michael B. Campion, Christopher D. Hofich, Dragana Milosevic, Jesse S. Voss, Beth A. Pitel, Lori S. Tillmans, Amanda M. Ward, Lisa M. Peterson, Theodore J. Stier, Julie Swank, Jing Peng, Kevin C. Halling, M.D., Ph.D, Benjamin R. Kipp, Ph.D., Zhiyv Niu Ph.D., Gang Zheng, M.D., Ph.D.

Get Email Updates

Stay current by signing up to receive the latest news and updates on tests and services.  Sign up for the Labcorp Oncology View now!